Need a new search?

If you didn't find what you were looking for, try a new search!

The Ham-D is not Hamilton’s Depression Scale + Commentary on the Hamilton Rating Scale for Depression by Leon I. Rosenberg & Michael E. Thase

By |2022-10-21T14:47:51-07:00May 31st, 2022|, |

Review Article + Commentary The Ham-D is not Hamilton’s Depression Scale + Commentary on the Hamilton Rating Scale for Depression: 60+ Years Old and Still Relevant to the Assessment of Antidepressant Treatment Outcomes  By Leon I. Rosenberg, Michael E. Thase

Comments Off on The Ham-D is not Hamilton’s Depression Scale + Commentary on the Hamilton Rating Scale for Depression by Leon I. Rosenberg & Michael E. Thase

Michael E. Thase, MD

By |2018-03-09T15:28:57-08:00March 7th, 2018|

Michael E. Thase, MD Michael E. Thase, MD, is the Editor-in-chief of Psychopharmacology Bulletin. Dr. Thase joined the faculty of the Perelman School of Medicine at the University of Pennsylvania in 2007 as Professor of Psychiatry after more than 27 years at the University of Pittsburgh Medical Center [...]

Comments Off on Michael E. Thase, MD

Michael E. Thase, MD: Editor’s Letter

By |2016-02-02T07:48:38-08:00February 2nd, 2016|, |

Michael E. Thase, MD EDITOR'S LETTER TWO NEW SECTIONS OFFER FURTHER CHECKS AND BALANCES: NEGATIVE AND FAILED CLINICAL TRIAL REPORTS AND INVITED COMMENTARY Michael E. Thase, MD

Comments Off on Michael E. Thase, MD: Editor’s Letter

New Goals in the Treatment of Depression: Moving Toward Recovery By Michael E. Thase, MD, and Philip T. Ninan, MD

By |2017-12-21T00:00:02-08:00December 15th, 2015||

New Goals in the Treatment of Depression: Moving Toward Recovery By Michael E. Thase, MD, and Philip T. Ninan, MD By Michael E. Thase, MD, and Philip T. Ninan, MD

Comments Off on New Goals in the Treatment of Depression: Moving Toward Recovery By Michael E. Thase, MD, and Philip T. Ninan, MD

A Phase 2 Open Label Study of Efficacy, Safety, and Tolerability of SLS-002 (Intranasal Racemic Ketamine) in Adults with MDD at Imminent Risk of Suicide

By |2024-03-05T13:10:04-08:00March 5th, 2024|, |

Original Research A Phase 2 Open Label Study of Efficacy, Safety, and Tolerability of SLS-002 (Intranasal Racemic Ketamine) in Adults with MDD at Imminent Risk of Suicide By Timothy Whitaker, Kimberly F. Farrand, Michael E. Thase

Comments Off on A Phase 2 Open Label Study of Efficacy, Safety, and Tolerability of SLS-002 (Intranasal Racemic Ketamine) in Adults with MDD at Imminent Risk of Suicide

Adjunctive Pimavanserin in Patients with Major Depressive Disorder: Combined Results from Two Randomized, Double-Blind, Placebo-Controlled Phase 3 Studies

By |2022-10-21T14:49:32-07:00October 21st, 2022|, |

Original Research  Adjunctive Pimavanserin in Patients with Major Depressive Disorder: Combined Results from Two Randomized, Double-Blind, Placebo-Controlled Phase 3 Studies  Bryan Dirks, Maurizio Fava, Sarah D. Atkinson, Mark Joyce, Michael E. Thase, Becky Howell, Tim Lin, Serge Stankovic 

Comments Off on Adjunctive Pimavanserin in Patients with Major Depressive Disorder: Combined Results from Two Randomized, Double-Blind, Placebo-Controlled Phase 3 Studies

Commentary on the Hamilton Rating Scale for Depression: 60+ Years Old and Still Relevant to the Assessment of Antidepressant Treatment Outcomes

By |2022-10-21T14:47:53-07:00May 27th, 2022|, |

Commentary Commentary on the Hamilton Rating Scale for Depression: 60+ Years Old and Still Relevant to the Assessment of Antidepressant Treatment Outcomes  By Michael E. Thase

Comments Off on Commentary on the Hamilton Rating Scale for Depression: 60+ Years Old and Still Relevant to the Assessment of Antidepressant Treatment Outcomes

Suvorexant in the Treatment of Difficulty Falling and Staying Asleep (Insomnia)

By |2022-10-21T14:47:57-07:00March 4th, 2022|, |

Review Article Suvorexant in the Treatment of Difficulty Falling and Staying Asleep (Insomnia)  By Amnon A. Berger, Emily R. Sottosanti, Ariel Winnick, Joseph Keefe, Elasaf Gilbert, Jamal Hasoon, Michael E. Thase, Alan D. Kaye, Omar Viswanath, Ivan Urits 

Comments Off on Suvorexant in the Treatment of Difficulty Falling and Staying Asleep (Insomnia)

Articles in Press, 52.4.2022

By |2022-07-28T11:31:38-07:00January 31st, 2022|

ADHD-A Clinician’s Bird’s Eye View of Current Status and New Vistas! Ahmed Naguy1, MBBch, MSc , Prof. Saxby Pridmore2, MD, Salem Alwetayan3, MD, MRCPsych (UK), Dalal Elsori4, MD, ABP and Bibi Alamiri5, MD, ABPN, ScD Agomelatine Monotherapy for Autism- A Case Report Ahmed Naguy1, MBBch, MSc , Prof. Saxby Pridmore2, [...]

Comments Off on Articles in Press, 52.4.2022

IN PRESS: 52/1/2022

By |2022-02-10T07:40:30-08:00January 28th, 2022|Articles in Press, Brief Bulletins from the Field, We Know Psychiatry|

  ORIGINAL RESEARCH Doxepin for Insomnia: Executive Function before and after Treatment By Zhenghe YU, Li HAN, Pan YAN, Wenjuan LIU, Lishan REN, You XU, Lili YANG, Lisha MA, Youdan WEI, Yi LIU, Shengdong WANG DRUG DISPOSITION AND PHARMACOKINETICS Protein Biomarkers in Monocytes and CD4+ Lymphocytes for Predicting Lithium Treatment Response of [...]

Obesogenic Medications and Weight Gain Over 24 Weeks in Patients with Depression: Results from the GUIDED Study

By |2022-10-21T14:48:04-07:00November 11th, 2021|, |

Original Research Obesogenic Medications and Weight Gain Over 24 Weeks in Patients with Depression: Results from the GUIDED Study  Jess G. Fiedorowicz, Lisa Brown, James Li, Sagar V. Parikh, Boadie W. Dunlop, Brent P. Forester, Richard C. Shelton, Michael E. Thase, Matthew Macaluso, Kunbo Yu, John F. Greden 

Comments Off on Obesogenic Medications and Weight Gain Over 24 Weeks in Patients with Depression: Results from the GUIDED Study

Treatment of Insomnia with Zaleplon in HIV+ Significantly Improves Sleep and Depression

By |2022-10-21T14:48:08-07:00May 28th, 2021|, |

Original Research Treatment of Insomnia with Zaleplon in HIV+ Significantly Improves Sleep and Depression  By Jennifer R. Goldschmied, Arjun Sengupta, Anup Sharma, Lynne Taylor, Knashawn H. Morales, Michael E. Thase, Aalim Weljie, and Matthew S. Kayser 

Comments Off on Treatment of Insomnia with Zaleplon in HIV+ Significantly Improves Sleep and Depression

Development of a Patient-Centered Software System to Facilitate Effective Management of Bipolar Disorder

By |2022-10-21T14:48:10-07:00April 5th, 2021|, |

Original Research  Development of a Patient-Centered Software System to Facilitate Effective Management of Bipolar Disorder  By Charles L. Bowden, Richard Priesmeyer, Mauricio Tohen, Vivek Singh, Joseph R. Calabrese, Terry Ketter, Andrew Nierenberg, Michael E. Thase, Gregg Siegel, Leslie H. Siegel, Jim Mintz, Rif S. El-Mallakh, Susan L. McElroy, Melissa Martinez 

Comments Off on Development of a Patient-Centered Software System to Facilitate Effective Management of Bipolar Disorder

Patient Response Trajectories in Major Depressive Disorder

By |2022-10-21T14:48:32-07:00September 14th, 2020|, |

Original Research Patient Response Trajectories in Major Depressive Disorder Klaus G. Larsen, Sidney H. Kennedy, Elin Heldbo Reines, Michael E. Thase

Comments Off on Patient Response Trajectories in Major Depressive Disorder

Cariprazine Augmentation to Antidepressant Therapy in Major Depressive Disorder: Results of a Randomized, Double-Blind, Placebo-Controlled Trial

By |2022-10-21T14:48:57-07:00September 11th, 2018||

Original Research Cariprazine Augmentation to Antidepressant Therapy in Major Depressive Disorder: Results of a Randomized, Double-Blind, Placebo-Controlled Trial By Willie R. Earley, Hua Guo, György Németh, Judit Harsányi, Michael E. Thase

Comments Off on Cariprazine Augmentation to Antidepressant Therapy in Major Depressive Disorder: Results of a Randomized, Double-Blind, Placebo-Controlled Trial

Psychopharmacology Bulletin VOL 48 No. 4, 2018 – Full Issue Stacked PDF

By |2022-10-21T14:48:58-07:00June 8th, 2018|, , |

This product is the full issue of Psychopharmacology Bulletin VOL 48 No. 4. Upon purchase, you will receive a single downloadable PDF file with all this issues articles stacked from front cover to back cover.

Comments Off on Psychopharmacology Bulletin VOL 48 No. 4, 2018 – Full Issue Stacked PDF
Go to Top